A program to improve cervical cancer screening for women living with HIV in West Africa
West Africa Self-Sampling HPV Based Cervical Cancer Control Program (WA-SS-HCCP) for WLWHA: Barriers, challenges, and needs
This study is testing a new way for women living with HIV in West Africa to check for HPV, which can lead to cervical cancer, by using easy self-sampling methods that help them take control of their health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10906797 on NIH RePORTER |
What this research studies
This research focuses on implementing a self-sampling HPV testing program aimed at women living with HIV in West Africa, where cervical cancer rates are alarmingly high. The program seeks to identify women at risk of cervical cancer through cost-effective and accessible testing methods. By leveraging existing healthcare systems and partnerships in Mali and Nigeria, the project aims to overcome barriers to cervical cancer screening and treatment. Patients will be involved in the self-sampling process, which empowers them to take charge of their health.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living with HIV in West Africa, particularly those who may not have access to traditional cervical cancer screening methods.
Not a fit: Patients who do not live in West Africa or who are not living with HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer incidence and mortality among women living with HIV in West Africa.
How similar studies have performed: Previous research has shown that self-sampling HPV tests can be effective in increasing cervical cancer screening rates in similar populations, indicating a promising approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Hou, Lifang — Northwestern University at Chicago
- Study coordinator: Hou, Lifang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.